ScholarWorks@Gachon: Lee, Sang Pyo

Detailed Information

Lee, Sang Pyo (이상표)

College of Medicine (Department of Medicine)

Research Area: 호흡기내과

Tel 032-458-2682
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Allergy:6||Asthma:3||Immunotherapy:3||Allergic rhinitis:3||.:3||Chronic obstructive pulmonary disease:2||Injections:2||Skin prick test:2||Idiopathic pulmonary fibrosis:2||Dogs:2||Intralymphatic:2||Intralymphatic injection:2||Laboratory animal:2||Treatment efficacy:2||Food allergy:2||Microbiota:2||Allergen:2||Apoptosis:2||Immunologic desensitization:2||Eosinophilic gastroenteritis:2||Bone marrow involvement:1||Bronchial diseases:1||Burden:1||Cat:1||Cats:1||Chemotherapy:1||Chronic Cough:1||Chronic cough:1||ChurgStrauss syndrome:1||Cigarette smoke:1||Cisplatin:1||Classification:1||Codeine:1||Colorimetric Biosensors:1||Componentresolved diagnostics:1||Computational biology:1||Cor pulmonale:1||Desensitization:1||Diabetes Mellitus:1||Diarrhea:1||Dog:1||Endoscopy:1||Environmental measures:1||Enzymelinked immunosorbent assay:1||Eosinophile:1||Eosinophilic granulomatosis with polyangiitis:1||Epidemiology:1||Exhalation:1||FIP1L1PDGFRA:1||Furry pet animal:1||Gastrointestinal cancer:1||Healthcare utilization:1||High Resolution Computed Tomography:1||Hydrofluoric acid (HFA):1||Hydrofluorocarbons (HF):1||Hypereosinophilic syndrome:1||Hypersensitivity:1||Idiopathic Pulmonary Fibrosis:1||Iloprost:1||Immunologic:1||Immunologic hyposensitization:1||Infusionrelated reaction:1||Injection:1||Intestinal obstruction:1||Intradermal injection:1||Kidney injury:1||Levodropropizine Visual Analogue Scale:1||Lung cancer / Oncology:1||MPT64 Antibody:1||Magnetic Nanoparticles:1||Mesothelioma:1||Metagenome:1||Metastasis:1||MeteredDose Inhalers:1||Methotrexate:1||Microbiome:1||Migraine:1||Molecular targeted therapy:1||Nitric Oxide:1||NonHodgkin lymphoma:1||Nontuberculous mycobacteria:1||Nontuberculous mycobacterial pulmonary disease:1||Nontuberculous mycobacterium:1||PDE4 inhibitor:1||Panonychus citri:1||Particle Size:1||Peroxidase Mimic:1||Pleura:1||Pneumocystis jirovecii:1||PostOrgasmic illness:1||Preference:1||Prevalence:1||Pulmonary alveolar proteinosis (PAP):1||Pulmonary emphysema:1||Pulmonary fibrosis:1||Pulmonary hypertension:1||Quality of life:1||Questionnaire survey:1||Rapidly progressive glomerulonephritis:1||Reactive oxygen species:1||Respiratory Disease:1||Respiratory function tests:1||Rhinitis:1||Rituximab:1||Safety:1||Semen:1||Sensitization:1||Serum specific IgE:1||Shellfish:1||Small cell lung carcinoma:1||Specific IgE:1||Toxocara canis:1||Toxocariasis:1||Transcutaneous administration:1||Transforming growth factor β:1||Treatment Outcome:1||Tuberculosis:1||Tuberculosis, pulmonary:1||Tuberculous destroyed lung:1||Unmet needs:1||Veterinary researcher:1||Visceral larva migrans:1||adolescent:1||allergen:1||allergic:1||allergic rhinitis:1||allergy:1||aneurysm:1||aura:1||bronchial artery:1||cats:1||children:1||chronic obstructive pulmonary disease:1||cigarette smoke:1||clindamycin:1||cysteine protease:1||drug resistance:1||intralymphatic:1||intralymphatic immunotherapy:1||mite:1||patent foramen ovale:1||primaquine:1||protein kinase C:1||receptor for advanced glycation end product:1||stentgraft:1||sulfamethoxazole:1||trimethoprim:1||개회충:1||과민반응:1||분류:1||사회적 부담:1||알레르겐:1||알레르기:1||알레르기비염:1||역학:1||호산구:1||Abalone:1||Adolescent:1||Advanced glycation end products:1||Adverse effects:1||Adverse events:1||Air pollutants:1||Allergen immunotherapy:1||Allergenspecific immunotherapy:1||Allergens:1||Allergic symptom:1||Anaphylaxis:1||Animals:1||Aptamer:1||Arthiritis, rheumatoid:1||Atopic dermatitis:1||Belotecan:1||Biomarkers:1||Biopsy:1||Body mass index:1||

STATISTICS: Total View :3,677,651; Today View :1,690

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE